Parallel trade

The parallel trade business model is based on the unified market principles of the European Union, the free movement of goods and services.

Pricing strategies of the manufacturers are different in the EU countries, and also the exchage rates are constantly changing. As a result, the price of the same medicine is different in each country, therefore parallel trading has been a general practice for many years.

The import medicines must have the same therapeutic attributes that the reference products present have in the importing country.

In Europe, the total turnover of parallel trade is approximately 5-6 billion Euros, half of which is turned over by Germany; however, several Hungarian companies have also joined parallel trade.

EU Pharma Kft. has partners in Germany, Austria, Poland, Italy, Bulgaria, The Netherlands, Denmark, Slovenia, Estonia, Romania, Czech Republic, Latvia and Lithuania, and is open for new partnerships in other countries as well.